MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$2,080,583K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Payables to cms
Sale of investments
Net income
Others
Negative Cash Flow Breakdown
Purchase of investments
Reinsurance recoverable
Other assets
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Non-cash inducement payment for convertible note conversion (note 9)
-
-
13,336
-
Net income
361,828
679,023
-352,434
-137,484
Change in provision for credit losses
48,127
-55
-54
-70
Stock-based compensation expense
20,654
15,969
18,085
20,485
Depreciation and amortization expense
6,031
7,018
7,880
7,312
Amortization of debt issuance costs
1,148
1,015
856
385
Net accretion of investments
8,208
7,077
6,727
7,399
Premiums and accounts receivable
-
-
-2,908
-19,970
Deferred taxes
-1,527
-6,204
2,624
-175
Risk adjustment transfer receivable
-
-
-36,516
4,964
Net realized gain on sale of financial instruments
1,728
4
37
1,171
Reinsurance recoverable
54,057
42,737
-59,641
-33,307
Accounts receivable
-158,840
224,288
-
-
Receivables from cms
-41,444
86,165
-
-
Other assets
32,004
-5,344
-2,643
3,247
Payables to cms
1,372,045
1,993,149
-
-
Premium deficiency reserve
-
-
0
0
Benefits payable
164,384
278,666
-109,010
12,763
Accounts payable and other liabilities
22,415
-2,007
93,890
-30,010
Unearned premiums
-4,498
5,800
89,087
7,627
Reinsurance payable
-2,549
1,533
-3,696
-6,105
Risk adjustment transfer payable
-
-
816,395
-875,882
Net cash provided by operating activities
2,092,345
2,618,980
671,903
-964,658
Sale of investments
948,943
35,000
0
118,470
Maturity and paydowns of investments
254,700
299,243
192,551
210,754
Change in restricted deposits
-1,466
860
-1,050
-2,699
Purchase of investments
4,027,959
914,842
233,245
172,835
Purchase of property, equipment, and capitalized software
11,762
8,794
9,062
9,007
Inducement payment for convertible note conversion
-
-
4,445
-
Net cash used in investing activities
-2,834,612
-590,253
-48,706
150,081
Purchase of capped calls related to convertible notes
-
-
0
34,440
Proceeds from exercise of stock options and stock purchase agreement
28,765
1,139
12,841
12,897
Proceeds from long-term debt
-
-
0
410,000
Tax payments related to net settlement of share-based awards
11,920
0
0
1,746
Payments of debt issuance costs
180
4,739
225
22,677
Proceeds from joint venture contribution
-
-
0
-
Earn-out liability payout
3,370
-
-
-
Net cash provided by financing activities
13,295
-3,600
8,171
364,034
Increase in cash, cash equivalents and restricted cash equivalents
-728,972
2,025,127
631,368
-450,543
Cash, cash equivalents, restricted cash and cash equivalentsbeginning of period
4,829,250
2,804,123
2,260,305
2,260,305
Cash, cash equivalents, restricted cash and cash equivalentsend of period
4,100,278
4,829,250
2,804,123
2,172,755
Cash and cash equivalents
4,075,612
4,805,139
2,774,151
2,148,865
Restricted cash and cash equivalents included in restricted deposits
24,666
24,111
29,972
23,890
Total cash, cash equivalents and restricted cash and cash equivalents
4,100,278
4,829,250
2,804,123
2,172,755
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Payables to cms
$1,372,045K
Net income
$361,828K
(258.36%↑ Y/Y)
Benefits payable
$164,384K
(91.02%↑ Y/Y)
Accounts receivable
-$158,840K
Change in provision for
credit losses
$48,127K
(414.56%↑ Y/Y)
Proceeds from exercise of
stock options and...
$28,765K
(22.06%↑ Y/Y)
Receivables from cms
-$41,444K
Accounts payable and
other liabilities
$22,415K
(138.63%↑ Y/Y)
Stock-based compensation
expense
$20,654K
(-14.33%↓ Y/Y)
Depreciation and
amortization expense
$6,031K
(-13.47%↓ Y/Y)
Amortization of debt issuance
costs
$1,148K
(488.72%↑ Y/Y)
Net cash provided by
operating activities
$2,092,345K
(311.02%↑ Y/Y)
Net cash provided by
financing activities
$13,295K
(-39.93%↓ Y/Y)
Canceled cashflow
$104,571K
Canceled cashflow
$15,470K
Increase in cash, cash
equivalents and restricted...
-$728,972K
(-300.82%↓ Y/Y)
Canceled cashflow
$2,105,640K
Sale of investments
$948,943K
Maturity and paydowns of
investments
$254,700K
(128.40%↑ Y/Y)
Change in restricted
deposits
-$1,466K
(-178.71%↓ Y/Y)
Reinsurance recoverable
$54,057K
(949.45%↑ Y/Y)
Other assets
$32,004K
(141.59%↑ Y/Y)
Net accretion of
investments
$8,208K
(2.68%↑ Y/Y)
Unearned premiums
-$4,498K
(-219.46%↓ Y/Y)
Reinsurance payable
-$2,549K
(75.16%↑ Y/Y)
Net realized gain on
sale of financial...
$1,728K
(14300.00%↑ Y/Y)
Deferred taxes
-$1,527K
(-4141.67%↓ Y/Y)
Tax payments
related to net...
$11,920K
(731.24%↑ Y/Y)
Earn-out liability
payout
$3,370K
Payments of debt issuance
costs
$180K
Net cash used in
investing activities
-$2,834,612K
(-1585.19%↓ Y/Y)
Canceled cashflow
$1,205,109K
Purchase of investments
$4,027,959K
(1386.50%↑ Y/Y)
Purchase of property,
equipment, and capitalized...
$11,762K
(26.79%↑ Y/Y)
Buy us a coffee
OSCR_BIG copy-svg-svg
Oscar Health, Inc. (OSCR)
OSCR_BIG copy-svg-svg
Oscar Health, Inc. (OSCR)
🚨
Price Alert:
The stock price dropped by 10.66% after the earning call.
Show more